Consensus statement on preventive and symptomatic care of leukodystrophy patients
- 1 April 2015
- journal article
- review article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 114 (4), 516-526
- https://doi.org/10.1016/j.ymgme.2014.12.433
Abstract
No abstract availableKeywords
Funding Information
- Members of the Leukodystrophy Alliance
- The Department of Genetics, Children's National Health System, Washington DC, and Marshall Summar
- The Department of Neurology, Children's National Health System, Washington DC, and Phillip Pearl
- National Organization for Rare Disorders
- Montreal Children's Hospital and McGill University Health Center Research Institutes
- RMAG (Réseau de Médecine Génétique Appliquée)
- Fondation sur les Leucodystrophies
- Fondation du Grand défi Pierre Lavoie
- Fondation Les Amis D'Élliot
- Fondation Désirée le Papillon, Genome Canada
- Canadian Institutes of Health Research
This publication has 38 references indexed in Scilit:
- Disease specific therapies in leukodystrophies and leukoencephalopathiesMolecular Genetics and Metabolism, 2015
- A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathiesMolecular Genetics and Metabolism, 2015
- Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic LeukodystrophyScience, 2013
- Neural Stem Cell Engraftment and Myelination in the Human BrainScience Translational Medicine, 2012
- Consensus Statement on Standard of Care for Congenital MyopathiesJournal of Child Neurology, 2012
- GFAP mutations, age at onset, and clinical subtypes in Alexander diseaseNeurology, 2011
- Managing Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The burden of inherited leukodystrophies in childrenNeurology, 2010
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked AdrenoleukodystrophyScience, 2009
- Treatment of dystoniaThe Lancet Neurology, 2006